top of page

Patients Flock To Florida’s Medical Marijuana Program, Driving Surge In Job Growth

  • Writer: Bob Marley
    Bob Marley
  • Feb 21, 2021
  • 3 min read

That growth is expected to continue, with sales projected to top $6 billion in annual sales by 2030 in Florida.

By John Haughey | The Center Square

The medical marijuana market in Florida created nearly 15,000 new jobs in 2020 and employs an estimated 31,444 state residents, according to a new analysis.

Florida recorded nearly $1.23 billion in marijuana sales in 2020, according to the report posted by Leafly and Whitney Economics. Florida’s sales were more than every state except California and Colorado, where marijuana is legal for adults.

Medical marijuana patient registrations surged in Florida last year, with 170,000 new patients in 2020. According to the state’s Office of Medical Marijuana Use’s (OMMU) Feb. 12 update, 485,693 state residents are “qualified” patients who can receive prescriptions from 2,644 licensed physicians to purchase marijuana at 313 dispensaries statewide.

That growth is expected to continue, with sales projected to top $6 billion in annual sales by 2030 in Florida.

But Leafly and Whitney Economics said the state could recoup a far greater benefit if it legalized marijuana for adults and/or did away with its cumbersome, and possibly unconstitutional, regulatory scheme.

“With a state population of nearly 22 million, Florida could reasonably double its current total of cannabis jobs if it chose to legalize for all adults,” the report said.

If any of the several 2021 legalization bills are adopted, Leafly and Whitney Economics projects Florida’s marijuana market would boom to $2.1 billion in sales and generate $800 million in state and local taxes while employing more than 60,000.

Among the bills is House Bill 343, filed by Rep. Carlos Guillermo Smith, D-Orlando. It would legalize marijuana for adults over age 21 and establish a “robust and free-market regulatory approach.”

Assigned to four committees, HB 343 has not been heard. Senate companion, Senate Bill 710, filed by Sen. Jeff Brandes, R-St. Petersburg, faces a similar four-committee slog and has not been heard.

Florida law requires OMMU to issue medical marijuana licenses – limited to 22 with only 15 issued – to corporations that are “vertically integrated,” meaning they must handle the product from seed to sale.

A Tallahassee appellate court ruled in July the system was unconstitutional. The case will be heard by the Florida Supreme Court on March 1.

Lawmakers, however, don’t want to wait for the court ruling and have filed bills seeking to expand opportunities for small businesses.

Among them are Senate Bill 562 and Senate Bill 564 by Sen. Perry Thurston, D-Fort Lauderdale, and House Bill 593 and House Bill 595 by Rep. Angie Nixon, D-Jacksonville.

SB 562/HB 593 would prohibit retailers from producing their own products, which they are required to do under the state’s vertical integration scheme.

SB 564/HB 595 would require OMMU to impose initial application and biennial renewal fees for licensing of marijuana retail facilities, boosting state coffers, potentially, by hundreds of millions.

None has been heard before assigned committees.

What is certain to be heard is an unfiled bill seeking to cap THC content, Senate President Wilton Simpson, R-Trilby, said this week.

“It’s certainly on the table,” he said.

Former House Speaker Jose Oliva, R-Miami Lakes, said last year THC should be capped because European “super-strains” entering U.S. markets produce “schizophrenic results, especially in young, developing brains.”

Proposals to cap THC at 10 percent drew protests by veterans’ groups and was opposed by influential Republicans, including Brandes. An attempt to cap THC at 10 percent for patients under 21 years old failed.

Discussion about THC caps emerged after Dr. Bertha Madras, a Harvard University psychobiologist and anti-cannabis activist, addressed the House Health & Human Services Committee for the fourth consecutive session on the dangers of high-potency marijuana.

“I’m not sure if I should start running for the hills,” Smith quipped afterward, “or start running for a dispensary to relieve my anxiety.”

This story was first published by The Center Square.

Lawmakers Voted To Approve Marijuana Legalization Bills In Four States This Week

Comments


Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page